Thursday, May 26, 2022 9:53:53 AM
What chance does aviptadil have with no supportive data over placebo in primary & secondary end points of mortality? Do these studies consider patients medical history of chronic diseases & General overall health? Plus at what stage of illness is this data obtained? You have testimonials of this miraculous drug by physicians treating critical ill covi d patients. Then you have these data results of clinical trials on aviptadil vs placebo. Is this another plot to delay approval again for aviptadil? Yet India gives eua for aviptadil! I say approve the drug period! It's safe & effective more So than Remdesiver!....
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM